2018
DOI: 10.5114/reum.2018.79506
|View full text |Cite
|
Sign up to set email alerts
|

Antimalarials – are they effective and safe in rheumatic disease? Focus on the neuropsychiatric side effects

Abstract: Neuropsychiatric manifestations are uncommon adverse events in patients with rheumatic diseases, when treated with chloroquine (CQ) or hydroxychloroquine (HCQ). This possibility is related to their ability to cross the blood-brain barrier ; in the brain, they have a tissue concentration up to10-20 times higher than the plasmatic one. A great variety of neuropsychiatric side effects was referred to CQ/HCQ; in some cases, they caused the patient' s hospitalization or death. Personal previous psychiatric sym… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…It is an important drug for the treatment of malaria and rheumatic diseases. [2][3][4][5] There is also some literature suggesting that HCQ can be used for tumor therapy. [6] The salt form of an Active Pharmaceutical Ingredient (API) has a long and successful track record in modifying its physicochemical and biopharmaceutical properties.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is an important drug for the treatment of malaria and rheumatic diseases. [2][3][4][5] There is also some literature suggesting that HCQ can be used for tumor therapy. [6] The salt form of an Active Pharmaceutical Ingredient (API) has a long and successful track record in modifying its physicochemical and biopharmaceutical properties.…”
Section: Introductionmentioning
confidence: 99%
“…It is an important drug for the treatment of malaria and rheumatic diseases. [ 2–5 ] There is also some literature suggesting that HCQ can be used for tumor therapy. [ 6 ]…”
Section: Introductionmentioning
confidence: 99%